Skip to main content
. 2026 Sep 12;46(11):1279–1297. doi: 10.1007/s40261-026-01595-3

Table 1.

Latin square group design and treatment periods

Period 1 Period 2 Period 3 Period 4
Group 1 A B C D
Group 2 B D C A
Group 3 C A D B
Group 4 D C B A

A, dronabinol 5 mg, fasted; B, acetazolamide 250 mg, fasted; C, IHL-42X (5 mg dronabinol, 250 mg acetazolamide), fasted; D, IHL-42X (5 mg dronabinol, 250 mg acetazolamide), fed.